Streetbeat News

IGM

iShares Expanded Tech Sector ETF

https://www.ishares.com/us/products/239769/ishares-north-american-tech-etf

Industry

Asset Management

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. A significant portion of the underlying index is represented by securities of companies in the technology industry or sector. It is non-diversified.

Open

104.51

Mkt cap

5.8B

Volume

224K

High

104.51

P/E Ratio

35.87

52-wk high

107.19

Low

103.36

Div yield

0.00

52-wk low

76.86

Pomerantz Law Firm is investigating claims on behalf of investors of IGM Biosciences, Inc. (NASDAQ:IGMS). Investors are encouraged to contact the firm for more information.

Portfolio Pulse from

January 16, 2025 | 11:30 pm

IGM Biosciences is cutting 73% of its workforce after an unsuccessful autoimmune-drug trial, marking another setback for the company.

Portfolio Pulse from

January 09, 2025 | 7:45 pm

IGM Biosciences is halting the development of its autoimmune pipeline programs, specifically imvotamab and IGM-2644, and is reducing its workforce by 73%. The company reported cash and investments of $183.8 million as of December 31, 2024.

Portfolio Pulse from

January 09, 2025 | 6:15 pm

The article discusses the iShares Expanded Tech Sector ETF (IGM), which provides broad exposure to the Technology sector. It is a passively managed ETF launched in 2001.

Portfolio Pulse from

December 24, 2024 | 12:30 pm

Artificial intelligence (AI) has become a major focus for investors, driving tech companies' stocks to historic highs. The article suggests that investing in an AI-focused ETF could be a smart move.

Portfolio Pulse from

December 24, 2024 | 11:45 am

The iShares Expanded Tech Sector ETF (IGM) offers broad tech exposure but poses concentration risk due to its heavy weighting in semiconductors, interactive media, application software, and systems software. It has a higher expense ratio and has underperformed compared to XLK and VGT.

Portfolio Pulse from

December 09, 2024 | 7:00 am

The article discusses the potential of the iShares Expanded Tech Sector ETF (IGM) as a 'millionaire maker' investment, highlighting the historical impressive returns of technology stocks.

Portfolio Pulse from

November 29, 2024 | 9:45 am

IGM Biosciences released its Q3 2024 financial results and provided a corporate update. The company is continuing trials for Imvotamab in rheumatoid arthritis, systemic lupus erythematosus, and myositis, with initial clinical data expected by mid-2025.

Portfolio Pulse from

November 08, 2024 | 12:15 pm

The IMF warns that while AI can enhance market efficiency, it also poses risks of increased volatility and cyber threats. AI-driven trading, especially in equities and bonds, could lead to market instability. The IMF suggests enhancing regulation and supervision of AI-related activities.

Portfolio Pulse from Pooja Rajkumari

October 16, 2024 | 7:56 am

U.S. auto safety regulators are investigating Alphabet Inc's Waymo self-driving vehicles for potential traffic safety law violations after 22 incidents, including 17 collisions. The National Highway Traffic Safety Administration (NHTSA) is examining Waymo's 5th Generation automated driving system's performance in detecting and responding to traffic control devices. This investigation also includes other companies like GM's Cruise and Amazon's Zoox. Waymo has recalled 444 vehicles due to software errors in February and is cooperating with NHTSA.

Portfolio Pulse from Shivani Kumaresan

May 14, 2024 | 2:28 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.